Patent holdings for IPC class A61K 31/504

Total number of patents in this class: 71

10-year publication summary

4
3
2
2
3
9
8
3
12
4
2015 2016 2017 2018 2019 2020 2021 2022 2023 2024

Principal owners for this class

Owner
All patents
This class
Revolution Medicines, Inc.
153
10
Gilead Sciences, Inc.
1879
5
Selcia Limited
10
4
F. Hoffmann-La Roche AG
7958
3
Chugai Seiyaku Kabushiki Kaisha
1259
3
Oncodesign S.A.
16
3
Hoffmann-La Roche Inc.
3060
2
Ipsen Pharma S.A.S.
402
2
University of Pittsburgh - Of the Commonwealth System of Higher Education
2912
2
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
211
2
Novartis AG
11238
1
Janssen Pharmaceuticals, Inc.
399
1
Merck Patent GmbH
5909
1
Bayer AG
3045
1
The Johns Hopkins University
5377
1
Takeda Pharmaceutical Company Limited
2961
1
ACADIA Pharmaceuticals Inc.
201
1
Actelion Pharmaceuticals Ltd
576
1
Astellas Pharma Inc.
1145
1
The Broad Institute, Inc.
1584
1
Other owners 25